Incyte (INCY) Tops Q3 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Incyte (INCY) PT Raised to $87 at Leerink Partners
October 30, 2024 6:26 AM EDTLeerink Partners analyst Andrew S. Berens raised the price target on Incyte (NASDAQ: INCY) to $87.00 (from $85.00) while maintaining a Outperform rating.
The analyst comments "Bottom Line: This morning, Incyte reported 3Q24 financial results and provided updates on the pipeline. INCY beat consensus on key product revenues, with... More
Incyte (INCY) PT Raised to $97 at Citi
October 30, 2024 5:47 AM EDTCiti analyst David Lebowitz raised the price target on Incyte (NASDAQ: INCY) to $97.00 (from $92.00) while maintaining a Buy rating.
The analyst comments "Incyte reported 3Q24 results, delivering topline revenue beats due to sustained growth for key franchise drivers in Jakafi and... More
Incyte (INCY) PT Raised to $84 at Jefferies
October 29, 2024 2:41 PM EDTJefferies analyst Kelly Shi raised the price target on Incyte (NASDAQ: INCY) to $84.00 (from $81.00) while maintaining a Buy rating.
The analyst comments "INCY delivered great Q with rev beat ($1.14B vs $1.08B cons) all around - Jakafi $741M (+5% QoQ vs $718M cons) and... More
